Dublin, Feb. 01, 2022 (GLOBE NEWSWIRE) -- The "Body Fat Reduction Market by Procedure Type, Gender, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
The global body fat reduction market was valued at $7,587.77 million in 2020, and is projected to reach $13,910.63 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.
Body fat is commonly the accumulation of adipose tissue, a complex connective tissue with specialized roles in metabolism and endocrine function. Body fat reduction, in the context of medicine, health, or physical fitness, refers to decrease in total body mass caused by loss of fluid, body fat adipose tissue, or lean mass, notably bone mineral deposits, muscle, tendon, and other connective tissue. Body fat removal techniques are often utilized in cosmetic surgery to eliminate excess adipose tissues or fats from the body either by a surgical or a non-surgical procedure.
Higher percentage of body fat leads to weight gain in individuals and further leads to obesity. Obesity is a complicated illness characterized by excess of body fat. Obesity is more than simply an aesthetic issue. It is a medical condition that raises the chance of developing other diseases and health issues, such as heart disease, diabetes, high blood pressure, and some malignancies. Obesity in males is defined as a proportion of body fat more than 25%, with 21-25% considered borderline. Obesity is defined as having a body mass index (BMI) of greater than 33% in women. The higher the proportion of body fat, the more probable is it to develop obesity-related diseases such as cardiac diseases, hypertension, higher chances of having a stroke, and type 2 diabetes.
According to the World Health Organization (WHO), most of the world's population live in countries where overweight and obesity kills more people than underweight individuals and 39 million children under the age of 5 were overweight or obese in 2020 globally. Overweight and obesity, formerly thought to be a problem only in high-income nations, are now on the rise in low and middle income countries, particularly in metropolitan areas. In Africa, the number of overweight children under 5 has increased by nearly 24% since 2000. Almost half of the children under 5 who were overweight or obese in 2019 live in Asia.
Growth of the global body fat reduction market is majorly driven by rise in consumption of carbohydrate-based foods, packaged foods, poor eating habits, and unhealthy lifestyle among young generation as well adults thus leading to weight gain and further obesity. Furthermore, according to the World Obesity Federation if the current trends continue, it is estimated that approximately 2.7 billion adults will be overweight, over 1 billion affected by obesity, and 177 million adults severely affected by obesity by 2025. Thus, surge in obesity population is expected to boost the body fat reduction market.
Moreover, rise in demand for aesthetic enhancement procedures such as cryolipolysis, laser lipolysis, liposuction, tummy tuck also known as abdominoplasty, ultrasound, injectable treatments, red light therapy, and others, owing to self-consciousness among the population, especially in women for beautification is on the rise. According to the American Society of Plastic Surgeons (ASPS) report in 2020, it is estimated that in America 15.6 million of cosmetic procedures were performed among which there were 2.3 million cosmetic surgical procedures and 13.2 million cosmetic minimally-invasive procedures. In addition, approximately $16.7 billion was spent on cosmetic procedures in the U.S.
In contrast, these procedures led to certain complications such as seroma, infections, necrosis as well as hematoma (bleeding under the skin), lumpy and uneven results, persistent numbness that can last for months, changes in skin color in the treated areas, pulmonary edema and others. Lack of reimbursement from insurance companies and high cost of the procedure is also a factor that may hinder the growth of the market. Technological advancements for body contouring like the cool sculpting and various innovation of such technologies is a great opportunity for the key players to invest in the emerging markets.
Furthermore, the COVID-19 pandemic resulted in a decrease in body fat reduction procedures globally, but the closure of parks, fitness centers, educational institutions, and the operation of work from home (WFH) culture resulted in an increase in weight gain issues and obesity cases, which is expected to boost market growth during the forecast period.
The body fat reduction market is segmented on the basis of procedure type, gender, end user, and region. On the basis of procedure type, the market is categorized into surgical and non-surgical. The surgical segment is further categorized into liposuction and abdominoplasty. Moreover, the non-surgical segment is subdivided into cryolipolysis, ultrasound, and others. On the basis of gender, the market is segregated into male and female. By end user, it is fragmented into hospitals & clinics, medical spas, and others.
Key Benefits
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global body fat reduction market to identify the prevailing opportunities.
- This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region- & country-wise analysis is provided to understand the market trends and dynamics.
Key Topics Covered:
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter's five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increasing prevalence of obesity
3.5.1.2. Growing focus on aesthetics and cosmetic surgeries
3.5.1.3. Technological advancements and rise in adoption of minimally invasive procedures
3.5.2. Restraint
3.5.2.1. High cost of procedures coupled with post treatment complications
3.5.3. Opportunity
3.5.3.1. New developments and increasing number of facilities offering fat reduction services
3.5.4. Impact analysis
3.6. COVID-19 impact analysis on the body fat reduction market
CHAPTER 4: BODY FAT REDUCTION MARKET, BY PROCEDURE
4.1. Overview
4.1.1. Market size and forecast
4.2. Surgical
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Market size and forecast, by type
4.2.4.1. Liposuction
4.2.4.1.1. Market size and forecast
4.2.4.2. Abdominoplasty
4.2.4.2.1. Market size and forecast
4.3. Non-Surgical
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.4. Market size and forecast, by type
4.3.4.1. Cryolipolysis
4.3.4.1.1. Market size and forecast
4.3.4.2. Ultrasound
4.3.4.2.1. Market size and forecast
4.3.4.3. Others
4.3.4.3.1. Market size and forecast
CHAPTER 5: BODY FAT REDUCTION MARKET, BY GENDER
5.1. Overview
5.1.1. Market size and forecast
5.2. Male
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Female
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
CHAPTER 6: BODY FAT REDUCTION MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & clinics
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Medical spas
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: BODY FAT REDUCTION MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
8.1. ABBVIE INC. (ALLERGAN INC.)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. APOLLO HOSPITALS ENTERPRISE LIMITED (APOLLO COSMETIC CLINICS)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INTERNATIONAL INC.)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. CANDELA MEDICAL
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.5. CUTERA INC.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. CYNOSURE, LLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments
8.7. LUMENIS LTD.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.8. SCITON, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments
8.9. SISRAM MEDICAL LTD (ALMA LASERS LTD.)
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. VLCC HEALTH CARE LTD.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
For more information about this report visit https://www.researchandmarkets.com/r/684jw6
